UMA H GOWDA

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology ROSEVILLE, CA NPI 1013976570

General Payments — all program years on this page

$40,233.55

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 118
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $3,305.76 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $1,925.001
Food and Beverage $1,380.7614

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $3,415.1723
2019 $2,718.8823
2020 $5,571.437
2021 $2,817.799
2022 $17,968.5430
2023 $4,435.9811
2024 $3,305.7615

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078320582 Janssen Biotech, Inc. $20.80 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078320606 Janssen Biotech, Inc. $29.40 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078320744 Janssen Biotech, Inc. $130.10 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086953087 Novartis Pharmaceuticals Corporation $25.94 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092737822 Boston Scientific Corporation $149.93 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101381326 E.R. Squibb & Sons, L.L.C. $121.89 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104380795 AstraZeneca Pharmaceuticals LP $112.12 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104755182 AstraZeneca Pharmaceuticals LP $1,925.00 11/20/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105560212 AstraZeneca Pharmaceuticals LP $102.33 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105567034 AstraZeneca Pharmaceuticals LP $110.53 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105789330 AstraZeneca Pharmaceuticals LP $110.68 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120850042 BeiGene USA, Inc. $112.65 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120850044 BeiGene USA, Inc. $115.38 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131477787 PFIZER INC. $122.94 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141627357 Merck Sharp & Dohme LLC $116.07 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.